nodes	percent_of_prediction	percent_of_DWPC	metapath
Sulfadiazine—CYP3A4—Temozolomide—malignant glioma	0.474	1	CbGbCtD
Sulfadiazine—Skin necrosis—Carmustine—malignant glioma	0.0211	0.0935	CcSEcCtD
Sulfadiazine—CYP2C8—Arachidonate Epoxygenase / Epoxide Hydrolase—COX8A—malignant glioma	0.0195	0.0706	CbGpPWpGaD
Sulfadiazine—CYP2C8—Diclofenac Metabolic Pathway—CYP2B6—malignant glioma	0.0185	0.0669	CbGpPWpGaD
Sulfadiazine—CYP2C8—Diclofenac Metabolic Pathway—CYP2C18—malignant glioma	0.016	0.058	CbGpPWpGaD
Sulfadiazine—CYP2C9—Arachidonate Epoxygenase / Epoxide Hydrolase—COX8A—malignant glioma	0.0159	0.0574	CbGpPWpGaD
Sulfadiazine—Burning sensation—Carmustine—malignant glioma	0.0106	0.047	CcSEcCtD
Sulfadiazine—CYP2E1—CYP2E1 reactions—CYP2B6—malignant glioma	0.00953	0.0345	CbGpPWpGaD
Sulfadiazine—CYP2C8—CYP2E1 reactions—CYP2B6—malignant glioma	0.00824	0.0298	CbGpPWpGaD
Sulfadiazine—Skin exfoliation—Carmustine—malignant glioma	0.00703	0.0312	CcSEcCtD
Sulfadiazine—CYP2E1—Oxidation by Cytochrome P450—POR—malignant glioma	0.00696	0.0252	CbGpPWpGaD
Sulfadiazine—Skin exfoliation—Temozolomide—malignant glioma	0.00679	0.0301	CcSEcCtD
Sulfadiazine—CYP2C9—CYP2E1 reactions—CYP2B6—malignant glioma	0.00671	0.0242	CbGpPWpGaD
Sulfadiazine—Aplastic anaemia—Temozolomide—malignant glioma	0.00668	0.0296	CcSEcCtD
Sulfadiazine—Sepsis—Carmustine—malignant glioma	0.00639	0.0284	CcSEcCtD
Sulfadiazine—CYP2C8—Oxidation by Cytochrome P450—POR—malignant glioma	0.00601	0.0217	CbGpPWpGaD
Sulfadiazine—CYP2E1—Xenobiotics—CYP2B6—malignant glioma	0.00591	0.0214	CbGpPWpGaD
Sulfadiazine—Vascular purpura—Temozolomide—malignant glioma	0.00577	0.0256	CcSEcCtD
Sulfadiazine—CYP2C8—Arachidonate Epoxygenase / Epoxide Hydrolase—GSTP1—malignant glioma	0.00575	0.0208	CbGpPWpGaD
Sulfadiazine—Dermatitis exfoliative—Temozolomide—malignant glioma	0.00547	0.0243	CcSEcCtD
Sulfadiazine—Purpura—Temozolomide—malignant glioma	0.00536	0.0238	CcSEcCtD
Sulfadiazine—CYP2E1—Xenobiotics—CYP2C18—malignant glioma	0.00512	0.0185	CbGpPWpGaD
Sulfadiazine—CYP2C8—Xenobiotics—CYP2B6—malignant glioma	0.00511	0.0185	CbGpPWpGaD
Sulfadiazine—Ataxia—Carmustine—malignant glioma	0.00503	0.0223	CcSEcCtD
Sulfadiazine—CYP2C9—Oxidation by Cytochrome P450—POR—malignant glioma	0.0049	0.0177	CbGpPWpGaD
Sulfadiazine—Ataxia—Temozolomide—malignant glioma	0.00486	0.0215	CcSEcCtD
Sulfadiazine—CYP3A4—Liver X Receptor Pathway—CYP2B6—malignant glioma	0.00477	0.0173	CbGpPWpGaD
Sulfadiazine—Sulfaphenazole—CYP2B6—malignant glioma	0.0047	0.196	CrCbGaD
Sulfadiazine—CYP2C9—Arachidonate Epoxygenase / Epoxide Hydrolase—GSTP1—malignant glioma	0.00468	0.0169	CbGpPWpGaD
Sulfadiazine—Toxic epidermal necrolysis—Temozolomide—malignant glioma	0.00465	0.0206	CcSEcCtD
Sulfadiazine—CYP2C8—Xenobiotics—CYP2C18—malignant glioma	0.00443	0.016	CbGpPWpGaD
Sulfadiazine—Sulfasalazine—PPARG—malignant glioma	0.00427	0.178	CrCbGaD
Sulfadiazine—CYP2E1—Tryptophan metabolism—ASMT—malignant glioma	0.00426	0.0154	CbGpPWpGaD
Sulfadiazine—Dapsone—CYP2C18—malignant glioma	0.00419	0.175	CrCbGaD
Sulfadiazine—CYP2C9—Xenobiotics—CYP2B6—malignant glioma	0.00416	0.015	CbGpPWpGaD
Sulfadiazine—Depression—Carmustine—malignant glioma	0.00411	0.0182	CcSEcCtD
Sulfadiazine—Neuropathy peripheral—Carmustine—malignant glioma	0.00404	0.0179	CcSEcCtD
Sulfadiazine—Stomatitis—Carmustine—malignant glioma	0.00401	0.0178	CcSEcCtD
Sulfadiazine—Depression—Temozolomide—malignant glioma	0.00397	0.0176	CcSEcCtD
Sulfadiazine—Stevens-Johnson syndrome—Temozolomide—malignant glioma	0.00395	0.0175	CcSEcCtD
Sulfadiazine—Neuropathy peripheral—Temozolomide—malignant glioma	0.0039	0.0173	CcSEcCtD
Sulfadiazine—Stomatitis—Temozolomide—malignant glioma	0.00388	0.0172	CcSEcCtD
Sulfadiazine—CYP2E1—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2B6—malignant glioma	0.00387	0.014	CbGpPWpGaD
Sulfadiazine—Hallucination—Carmustine—malignant glioma	0.00368	0.0163	CcSEcCtD
Sulfadiazine—CYP2C9—Xenobiotics—CYP2C18—malignant glioma	0.0036	0.013	CbGpPWpGaD
Sulfadiazine—Hepatitis—Temozolomide—malignant glioma	0.00357	0.0159	CcSEcCtD
Sulfadiazine—Hallucination—Temozolomide—malignant glioma	0.00356	0.0158	CcSEcCtD
Sulfadiazine—Erythema multiforme—Temozolomide—malignant glioma	0.00338	0.015	CcSEcCtD
Sulfadiazine—Tinnitus—Temozolomide—malignant glioma	0.00333	0.0148	CcSEcCtD
Sulfadiazine—CYP3A4—Oxidation by Cytochrome P450—POR—malignant glioma	0.00323	0.0117	CbGpPWpGaD
Sulfadiazine—Chills—Temozolomide—malignant glioma	0.00321	0.0142	CcSEcCtD
Sulfadiazine—Sulfasalazine—PTGS1—malignant glioma	0.00316	0.132	CrCbGaD
Sulfadiazine—Leukopenia—Carmustine—malignant glioma	0.00288	0.0128	CcSEcCtD
Sulfadiazine—CYP2C9—Constitutive Androstane Receptor Pathway—CYP2B6—malignant glioma	0.00285	0.0103	CbGpPWpGaD
Sulfadiazine—Vertigo—Temozolomide—malignant glioma	0.00279	0.0124	CcSEcCtD
Sulfadiazine—Convulsion—Carmustine—malignant glioma	0.00279	0.0124	CcSEcCtD
Sulfadiazine—Leukopenia—Temozolomide—malignant glioma	0.00278	0.0124	CcSEcCtD
Sulfadiazine—CYP3A4—Xenobiotics—CYP2B6—malignant glioma	0.00274	0.00991	CbGpPWpGaD
Sulfadiazine—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2B6—malignant glioma	0.00272	0.00983	CbGpPWpGaD
Sulfadiazine—Convulsion—Temozolomide—malignant glioma	0.00269	0.012	CcSEcCtD
Sulfadiazine—Arthralgia—Temozolomide—malignant glioma	0.00265	0.0118	CcSEcCtD
Sulfadiazine—CYP2E1—Tryptophan metabolism—CYP2C18—malignant glioma	0.00263	0.00951	CbGpPWpGaD
Sulfadiazine—Sulfamethoxazole—PTGS1—malignant glioma	0.00262	0.109	CrCbGaD
Sulfadiazine—Thrombocytopenia—Carmustine—malignant glioma	0.00257	0.0114	CcSEcCtD
Sulfadiazine—Anaphylactic shock—Temozolomide—malignant glioma	0.00254	0.0113	CcSEcCtD
Sulfadiazine—Anorexia—Carmustine—malignant glioma	0.0025	0.0111	CcSEcCtD
Sulfadiazine—Thrombocytopenia—Temozolomide—malignant glioma	0.00249	0.011	CcSEcCtD
Sulfadiazine—CYP2E1—Cytochrome P450 - arranged by substrate type—CYP2B6—malignant glioma	0.00245	0.00887	CbGpPWpGaD
Sulfadiazine—CYP2E1—Oxidation by Cytochrome P450—CYP2B6—malignant glioma	0.00242	0.00875	CbGpPWpGaD
Sulfadiazine—Anorexia—Temozolomide—malignant glioma	0.00242	0.0107	CcSEcCtD
Sulfadiazine—Musculoskeletal discomfort—Carmustine—malignant glioma	0.00239	0.0106	CcSEcCtD
Sulfadiazine—CYP3A4—Xenobiotics—CYP2C18—malignant glioma	0.00238	0.00859	CbGpPWpGaD
Sulfadiazine—Insomnia—Carmustine—malignant glioma	0.00238	0.0105	CcSEcCtD
Sulfadiazine—Musculoskeletal discomfort—Temozolomide—malignant glioma	0.00231	0.0103	CcSEcCtD
Sulfadiazine—Insomnia—Temozolomide—malignant glioma	0.0023	0.0102	CcSEcCtD
Sulfadiazine—Decreased appetite—Carmustine—malignant glioma	0.00228	0.0101	CcSEcCtD
Sulfadiazine—Gastrointestinal disorder—Carmustine—malignant glioma	0.00227	0.0101	CcSEcCtD
Sulfadiazine—CYP3A4—Irinotecan Pathway—BCHE—malignant glioma	0.00223	0.00805	CbGpPWpGaD
Sulfadiazine—Decreased appetite—Temozolomide—malignant glioma	0.00221	0.00979	CcSEcCtD
Sulfadiazine—Gastrointestinal disorder—Temozolomide—malignant glioma	0.00219	0.00972	CcSEcCtD
Sulfadiazine—Gastrointestinal pain—Carmustine—malignant glioma	0.00215	0.00953	CcSEcCtD
Sulfadiazine—CYP2E1—Cytochrome P450 - arranged by substrate type—CYP2C18—malignant glioma	0.00213	0.00769	CbGpPWpGaD
Sulfadiazine—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP2B6—malignant glioma	0.00212	0.00767	CbGpPWpGaD
Sulfadiazine—CYP2E1—Oxidation by Cytochrome P450—CYP2C18—malignant glioma	0.0021	0.00759	CbGpPWpGaD
Sulfadiazine—CYP2C8—Oxidation by Cytochrome P450—CYP2B6—malignant glioma	0.00209	0.00757	CbGpPWpGaD
Sulfadiazine—Body temperature increased—Carmustine—malignant glioma	0.00208	0.00921	CcSEcCtD
Sulfadiazine—Abdominal pain—Carmustine—malignant glioma	0.00208	0.00921	CcSEcCtD
Sulfadiazine—Gastrointestinal pain—Temozolomide—malignant glioma	0.00208	0.00921	CcSEcCtD
Sulfadiazine—Dapsone—PTGS1—malignant glioma	0.00205	0.0854	CrCbGaD
Sulfadiazine—Urticaria—Temozolomide—malignant glioma	0.00202	0.00895	CcSEcCtD
Sulfadiazine—Abdominal pain—Temozolomide—malignant glioma	0.00201	0.0089	CcSEcCtD
Sulfadiazine—Body temperature increased—Temozolomide—malignant glioma	0.00201	0.0089	CcSEcCtD
Sulfadiazine—CYP2E1—Phase 1 - Functionalization of compounds—CYP2B6—malignant glioma	0.00199	0.00719	CbGpPWpGaD
Sulfadiazine—CYP3A4—Tryptophan metabolism—ASMT—malignant glioma	0.00198	0.00714	CbGpPWpGaD
Sulfadiazine—Hypersensitivity—Carmustine—malignant glioma	0.00194	0.00859	CcSEcCtD
Sulfadiazine—CYP3A4—Constitutive Androstane Receptor Pathway—CYP2B6—malignant glioma	0.00188	0.0068	CbGpPWpGaD
Sulfadiazine—Hypersensitivity—Temozolomide—malignant glioma	0.00187	0.0083	CcSEcCtD
Sulfadiazine—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP2C18—malignant glioma	0.00184	0.00665	CbGpPWpGaD
Sulfadiazine—CYP2C8—Oxidation by Cytochrome P450—CYP2C18—malignant glioma	0.00181	0.00656	CbGpPWpGaD
Sulfadiazine—Sulfasalazine—PTGS2—malignant glioma	0.0018	0.0753	CrCbGaD
Sulfadiazine—Diarrhoea—Carmustine—malignant glioma	0.0018	0.00798	CcSEcCtD
Sulfadiazine—Pruritus—Temozolomide—malignant glioma	0.0018	0.00797	CcSEcCtD
Sulfadiazine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2B6—malignant glioma	0.00179	0.00648	CbGpPWpGaD
Sulfadiazine—Diarrhoea—Temozolomide—malignant glioma	0.00174	0.00771	CcSEcCtD
Sulfadiazine—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP2B6—malignant glioma	0.00173	0.00624	CbGpPWpGaD
Sulfadiazine—CYP2E1—Phase 1 - Functionalization of compounds—CYP2C18—malignant glioma	0.00172	0.00623	CbGpPWpGaD
Sulfadiazine—CYP2C8—Phase 1 - Functionalization of compounds—CYP2B6—malignant glioma	0.00172	0.00622	CbGpPWpGaD
Sulfadiazine—CYP2C9—Oxidation by Cytochrome P450—CYP2B6—malignant glioma	0.0017	0.00616	CbGpPWpGaD
Sulfadiazine—Vomiting—Carmustine—malignant glioma	0.00167	0.00741	CcSEcCtD
Sulfadiazine—Rash—Carmustine—malignant glioma	0.00166	0.00735	CcSEcCtD
Sulfadiazine—Dermatitis—Carmustine—malignant glioma	0.00165	0.00734	CcSEcCtD
Sulfadiazine—Headache—Carmustine—malignant glioma	0.00165	0.0073	CcSEcCtD
Sulfadiazine—Vomiting—Temozolomide—malignant glioma	0.00161	0.00716	CcSEcCtD
Sulfadiazine—CYP2C8—Arachidonic acid metabolism—PTGS1—malignant glioma	0.00161	0.00583	CbGpPWpGaD
Sulfadiazine—Rash—Temozolomide—malignant glioma	0.0016	0.0071	CcSEcCtD
Sulfadiazine—Dermatitis—Temozolomide—malignant glioma	0.0016	0.0071	CcSEcCtD
Sulfadiazine—Headache—Temozolomide—malignant glioma	0.00159	0.00706	CcSEcCtD
Sulfadiazine—Nausea—Carmustine—malignant glioma	0.00156	0.00692	CcSEcCtD
Sulfadiazine—Nausea—Temozolomide—malignant glioma	0.00151	0.00669	CcSEcCtD
Sulfadiazine—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP2C18—malignant glioma	0.0015	0.00541	CbGpPWpGaD
Sulfadiazine—CYP2C8—Phase 1 - Functionalization of compounds—CYP2C18—malignant glioma	0.00149	0.00539	CbGpPWpGaD
Sulfadiazine—CYP2C9—Oxidation by Cytochrome P450—CYP2C18—malignant glioma	0.00148	0.00534	CbGpPWpGaD
Sulfadiazine—CYP2E1—Tryptophan metabolism—CAT—malignant glioma	0.00144	0.00519	CbGpPWpGaD
Sulfadiazine—CYP2C9—Phase 1 - Functionalization of compounds—CYP2B6—malignant glioma	0.0014	0.00506	CbGpPWpGaD
Sulfadiazine—CYP2C9—Arachidonic acid metabolism—PTGS1—malignant glioma	0.00131	0.00474	CbGpPWpGaD
Sulfadiazine—CYP2E1—Phase 1 - Functionalization of compounds—PTGS1—malignant glioma	0.00131	0.00473	CbGpPWpGaD
Sulfadiazine—CYP2E1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—malignant glioma	0.00124	0.00447	CbGpPWpGaD
Sulfadiazine—CYP3A4—Tryptophan metabolism—CYP2C18—malignant glioma	0.00122	0.00441	CbGpPWpGaD
Sulfadiazine—CYP2C9—Phase 1 - Functionalization of compounds—CYP2C18—malignant glioma	0.00121	0.00439	CbGpPWpGaD
Sulfadiazine—CYP3A4—Irinotecan Pathway—APC—malignant glioma	0.00121	0.00437	CbGpPWpGaD
Sulfadiazine—Dapsone—PTGS2—malignant glioma	0.00117	0.0488	CrCbGaD
Sulfadiazine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2B6—malignant glioma	0.00114	0.00412	CbGpPWpGaD
Sulfadiazine—CYP2C8—Phase 1 - Functionalization of compounds—PTGS1—malignant glioma	0.00113	0.00408	CbGpPWpGaD
Sulfadiazine—CYP3A4—Oxidation by Cytochrome P450—CYP2B6—malignant glioma	0.00112	0.00406	CbGpPWpGaD
Sulfadiazine—CYP2E1—Biological oxidations—CYP2B6—malignant glioma	0.00106	0.00382	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metapathway biotransformation—CYP2B6—malignant glioma	0.00104	0.00377	CbGpPWpGaD
Sulfadiazine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2C18—malignant glioma	0.000987	0.00357	CbGpPWpGaD
Sulfadiazine—CYP3A4—Oxidation by Cytochrome P450—CYP2C18—malignant glioma	0.000974	0.00352	CbGpPWpGaD
Sulfadiazine—CYP3A4—Phase 1 - Functionalization of compounds—CYP2B6—malignant glioma	0.000923	0.00334	CbGpPWpGaD
Sulfadiazine—CYP2C9—Phase 1 - Functionalization of compounds—PTGS1—malignant glioma	0.000919	0.00332	CbGpPWpGaD
Sulfadiazine—CYP2E1—Biological oxidations—CYP2C18—malignant glioma	0.000916	0.00331	CbGpPWpGaD
Sulfadiazine—CYP2C8—Biological oxidations—CYP2B6—malignant glioma	0.000913	0.0033	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metapathway biotransformation—CYP2C18—malignant glioma	0.000904	0.00327	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metapathway biotransformation—CYP2B6—malignant glioma	0.000901	0.00326	CbGpPWpGaD
Sulfadiazine—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—malignant glioma	0.00087	0.00315	CbGpPWpGaD
Sulfadiazine—CYP3A4—Phase 1 - Functionalization of compounds—CYP2C18—malignant glioma	0.0008	0.00289	CbGpPWpGaD
Sulfadiazine—CYP2E1—Tryptophan metabolism—MDM2—malignant glioma	0.000793	0.00287	CbGpPWpGaD
Sulfadiazine—CYP2C8—Biological oxidations—CYP2C18—malignant glioma	0.000792	0.00286	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metapathway biotransformation—CYP2C18—malignant glioma	0.000781	0.00282	CbGpPWpGaD
Sulfadiazine—CYP2C9—Biological oxidations—CYP2B6—malignant glioma	0.000743	0.00269	CbGpPWpGaD
Sulfadiazine—CYP2E1—Biological oxidations—GSTT1—malignant glioma	0.000741	0.00268	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metapathway biotransformation—CYP2B6—malignant glioma	0.000733	0.00265	CbGpPWpGaD
Sulfadiazine—CYP2E1—Biological oxidations—PTGS1—malignant glioma	0.000694	0.00251	CbGpPWpGaD
Sulfadiazine—CYP3A4—Tryptophan metabolism—CAT—malignant glioma	0.000666	0.00241	CbGpPWpGaD
Sulfadiazine—CYP2C9—Biological oxidations—CYP2C18—malignant glioma	0.000644	0.00233	CbGpPWpGaD
Sulfadiazine—CYP2C8—Biological oxidations—GSTT1—malignant glioma	0.00064	0.00232	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metapathway biotransformation—CYP2C18—malignant glioma	0.000636	0.0023	CbGpPWpGaD
Sulfadiazine—CYP2C8—Arachidonic acid metabolism—PTGS2—malignant glioma	0.000618	0.00223	CbGpPWpGaD
Sulfadiazine—CYP3A4—Phase 1 - Functionalization of compounds—PTGS1—malignant glioma	0.000606	0.00219	CbGpPWpGaD
Sulfadiazine—CYP2C8—Biological oxidations—PTGS1—malignant glioma	0.0006	0.00217	CbGpPWpGaD
Sulfadiazine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—malignant glioma	0.000574	0.00208	CbGpPWpGaD
Sulfadiazine—CYP2C9—Biological oxidations—GSTT1—malignant glioma	0.000521	0.00188	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—RTEL1—malignant glioma	0.000519	0.00188	CbGpPWpGaD
Sulfadiazine—CYP2E1—Biological oxidations—GSTP1—malignant glioma	0.000514	0.00186	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metapathway biotransformation—GSTP1—malignant glioma	0.000507	0.00183	CbGpPWpGaD
Sulfadiazine—CYP2C9—Arachidonic acid metabolism—PTGS2—malignant glioma	0.000503	0.00182	CbGpPWpGaD
Sulfadiazine—CYP3A4—Biological oxidations—CYP2B6—malignant glioma	0.00049	0.00177	CbGpPWpGaD
Sulfadiazine—CYP2C9—Biological oxidations—PTGS1—malignant glioma	0.000488	0.00177	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metapathway biotransformation—CYP2B6—malignant glioma	0.000483	0.00175	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—RTEL1—malignant glioma	0.000449	0.00162	CbGpPWpGaD
Sulfadiazine—CYP2C8—Biological oxidations—GSTP1—malignant glioma	0.000444	0.0016	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metapathway biotransformation—GSTP1—malignant glioma	0.000438	0.00158	CbGpPWpGaD
Sulfadiazine—CYP3A4—Biological oxidations—CYP2C18—malignant glioma	0.000425	0.00154	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metapathway biotransformation—CYP2C18—malignant glioma	0.000419	0.00152	CbGpPWpGaD
Sulfadiazine—CYP3A4—Tryptophan metabolism—MDM2—malignant glioma	0.000368	0.00133	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—RTEL1—malignant glioma	0.000365	0.00132	CbGpPWpGaD
Sulfadiazine—CYP2C9—Biological oxidations—GSTP1—malignant glioma	0.000361	0.00131	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metapathway biotransformation—GSTP1—malignant glioma	0.000356	0.00129	CbGpPWpGaD
Sulfadiazine—CYP3A4—Biological oxidations—GSTT1—malignant glioma	0.000344	0.00124	CbGpPWpGaD
Sulfadiazine—CYP3A4—Biological oxidations—PTGS1—malignant glioma	0.000322	0.00116	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism of lipids and lipoproteins—IDH1—malignant glioma	0.000321	0.00116	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism of lipids and lipoproteins—SPHK1—malignant glioma	0.00031	0.00112	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—COX8A—malignant glioma	0.000298	0.00108	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism of lipids and lipoproteins—IDH1—malignant glioma	0.000261	0.000944	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—COX8A—malignant glioma	0.000258	0.000932	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—ASMT—malignant glioma	0.000254	0.000917	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism of lipids and lipoproteins—SPHK1—malignant glioma	0.000253	0.000913	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—RTEL1—malignant glioma	0.000241	0.000871	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—BCAN—malignant glioma	0.000238	0.000862	CbGpPWpGaD
Sulfadiazine—CYP3A4—Biological oxidations—GSTP1—malignant glioma	0.000238	0.000861	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metapathway biotransformation—GSTP1—malignant glioma	0.000235	0.00085	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism of lipids and lipoproteins—PTGS1—malignant glioma	0.00023	0.000833	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—ASMT—malignant glioma	0.000219	0.000792	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism of lipids and lipoproteins—BCHE—malignant glioma	0.000214	0.000775	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—COX8A—malignant glioma	0.00021	0.000759	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—BCAN—malignant glioma	0.000206	0.000745	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—IDH2—malignant glioma	0.000192	0.000695	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS1—malignant glioma	0.000188	0.000678	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—CYP2B6—malignant glioma	0.000181	0.000653	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—ASMT—malignant glioma	0.000178	0.000645	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—malignant glioma	0.000174	0.00063	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—BCAN—malignant glioma	0.000168	0.000606	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—IDH2—malignant glioma	0.000166	0.000601	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—IDH1—malignant glioma	0.000165	0.000597	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—SPHK1—malignant glioma	0.00016	0.000578	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—CYP2C18—malignant glioma	0.000157	0.000566	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	0.000157	0.000566	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—CYP2B6—malignant glioma	0.000156	0.000565	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—IDH1—malignant glioma	0.000143	0.000516	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—COX8A—malignant glioma	0.000138	0.0005	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—SPHK1—malignant glioma	0.000138	0.0005	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—CYP2C18—malignant glioma	0.000135	0.00049	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—IDH2—malignant glioma	0.000135	0.000489	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	0.000128	0.000462	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	0.000127	0.000461	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—CYP2B6—malignant glioma	0.000127	0.00046	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—GSTT1—malignant glioma	0.000127	0.000458	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—PTGS1—malignant glioma	0.000119	0.000429	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—ASMT—malignant glioma	0.000118	0.000425	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	0.000116	0.000421	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—IDH1—malignant glioma	0.000116	0.00042	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—SPHK1—malignant glioma	0.000113	0.000407	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	0.000112	0.000406	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—BCAN—malignant glioma	0.000111	0.0004	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—BCHE—malignant glioma	0.00011	0.000399	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—CYP2C18—malignant glioma	0.00011	0.000398	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—GSTT1—malignant glioma	0.00011	0.000396	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—SLC5A5—malignant glioma	0.000109	0.000394	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	0.000104	0.000376	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—PTGS1—malignant glioma	0.000103	0.000371	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	0.000102	0.00037	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—BCHE—malignant glioma	9.54e-05	0.000345	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	9.47e-05	0.000342	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—SLC5A5—malignant glioma	9.42e-05	0.000341	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	9.14e-05	0.00033	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—IDH2—malignant glioma	8.92e-05	0.000322	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—GSTT1—malignant glioma	8.91e-05	0.000322	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	8.91e-05	0.000322	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	8.83e-05	0.000319	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—GSTP1—malignant glioma	8.78e-05	0.000318	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—CAT—malignant glioma	8.55e-05	0.000309	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—CYP2B6—malignant glioma	8.38e-05	0.000303	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—PTGS1—malignant glioma	8.35e-05	0.000302	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	8.32e-05	0.000301	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—NCOR1—malignant glioma	8.07e-05	0.000292	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—BCHE—malignant glioma	7.77e-05	0.000281	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	7.7e-05	0.000278	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—SLC5A5—malignant glioma	7.67e-05	0.000277	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—IDH1—malignant glioma	7.67e-05	0.000277	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—GSTP1—malignant glioma	7.59e-05	0.000274	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—SPHK1—malignant glioma	7.42e-05	0.000268	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—CAT—malignant glioma	7.39e-05	0.000267	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—CYP2C18—malignant glioma	7.27e-05	0.000263	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	7.25e-05	0.000262	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	7.19e-05	0.00026	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—NCOR1—malignant glioma	6.98e-05	0.000252	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—CAV1—malignant glioma	6.58e-05	0.000238	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	6.27e-05	0.000227	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—GSTP1—malignant glioma	6.18e-05	0.000223	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—CAT—malignant glioma	6.01e-05	0.000217	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—PIK3CG—malignant glioma	5.99e-05	0.000217	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—GSTT1—malignant glioma	5.88e-05	0.000213	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—PPARG—malignant glioma	5.78e-05	0.000209	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—CAV1—malignant glioma	5.69e-05	0.000206	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—NCOR1—malignant glioma	5.68e-05	0.000205	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—PTGS1—malignant glioma	5.51e-05	0.000199	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	5.43e-05	0.000196	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—PIK3CD—malignant glioma	5.27e-05	0.00019	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—PIK3CG—malignant glioma	5.18e-05	0.000187	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—BCHE—malignant glioma	5.12e-05	0.000185	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—SLC5A5—malignant glioma	5.06e-05	0.000183	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—PPARG—malignant glioma	5e-05	0.000181	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—CAV1—malignant glioma	4.63e-05	0.000167	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—PIK3CB—malignant glioma	4.59e-05	0.000166	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—PIK3CD—malignant glioma	4.55e-05	0.000165	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—PTGS2—malignant glioma	4.55e-05	0.000164	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	4.42e-05	0.00016	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—PIK3CG—malignant glioma	4.22e-05	0.000152	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—GSTP1—malignant glioma	4.07e-05	0.000147	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—PPARG—malignant glioma	4.07e-05	0.000147	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—PIK3CB—malignant glioma	3.97e-05	0.000143	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—PTEN—malignant glioma	3.97e-05	0.000143	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—CAT—malignant glioma	3.97e-05	0.000143	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—PTGS2—malignant glioma	3.93e-05	0.000142	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—NCOR1—malignant glioma	3.74e-05	0.000135	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—PIK3CD—malignant glioma	3.71e-05	0.000134	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—PTEN—malignant glioma	3.43e-05	0.000124	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—PIK3CB—malignant glioma	3.23e-05	0.000117	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—PTGS2—malignant glioma	3.2e-05	0.000116	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—CAV1—malignant glioma	3.05e-05	0.00011	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—PIK3CA—malignant glioma	2.8e-05	0.000101	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—PTEN—malignant glioma	2.79e-05	0.000101	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—PIK3CG—malignant glioma	2.78e-05	0.000101	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—PPARG—malignant glioma	2.68e-05	9.7e-05	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—PIK3CD—malignant glioma	2.44e-05	8.84e-05	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—PIK3CA—malignant glioma	2.42e-05	8.75e-05	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—AKT1—malignant glioma	2.29e-05	8.27e-05	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—PIK3CB—malignant glioma	2.13e-05	7.7e-05	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—PTGS2—malignant glioma	2.11e-05	7.63e-05	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—AKT1—malignant glioma	1.98e-05	7.15e-05	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—PIK3CA—malignant glioma	1.97e-05	7.12e-05	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—PTEN—malignant glioma	1.84e-05	6.66e-05	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—AKT1—malignant glioma	1.61e-05	5.82e-05	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—PIK3CA—malignant glioma	1.3e-05	4.7e-05	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—AKT1—malignant glioma	1.06e-05	3.84e-05	CbGpPWpGaD
